Play

Brain organoids, cell collections grown in a lab to study diseases like Alzheimer’s, have created excitement because they are a bit more representative of a real brain. Johns Hopkins cell engineering expert Vasiliki Machairaki says there is another technique underway …

What is an assembloid? Elizabeth Tracey reports Read more »

Play

Using induced stem cells helps create models for diseases like Alzheimer’s disease that can be studied in a lab, but now three dimensional cell collections called organoids can also be developed from stem cells. Vasiliki Machairaki, a cell engineering expert …

What is an organoid? Elizabeth Tracey reports Read more »

Play

Stem cells used to be derived from human embryos, but not anymore. Now a simple blood test can allow stem cells to be induced from cells found there, says Johns Hopkins cell engineering expert Vasiliki Machairaki. Machairaki: Induced pluripotent stem …

How do stem cells derived from blood differ from those from embryos? Elizabeth Tracey reports Read more »

Play

Cells from your blood can be induced to return to what they looked like when you were an embryo, then can be made to develop into different cell types in the brain. That happens in the lab of Vasiliki Machairaki, …

Stem cells are just the beginning when it comes to modeling your risk for Alzheimer’s disease, Elizabeth Tracey reports Read more »

Play

A simple blood test may soon help precisely identify your risk for Alzheimer’s disease by inducing some of your cells to go back in time, looking like they did when you were an embryo. Johns Hopkins cell engineering expert Vasiliki …

What might reprogramming cells have to do with understanding Alzheimer’s? Elizabeth Tracey reports Read more »

Play

Hormone therapy for menopause has recently had a black box warning removed by the FDA, after the agency reexamined data originally prompting the warning and found it flawed. Wen Shen, a menopause expert at Johns Hopkins, says women still need …

Caveat emptor when it comes to hormone therapy for menopause, Elizabeth Tracey reports Read more »

Play

The FDA has recently removed black box warnings, indicating a medication is potentially risky, from hormone therapy for menopause. The warning was originally put on in 2003 after a study seemed to show increased risks for cardiovascular disease, breast cancer …

What is the controversy around hormone therapy for menopause? Elizabeth Tracey reports Read more »